|








| |
Journal of Bacteriology, June 2003, p . 3476-3479, Vol . 185,
No . 11
The
Glycosyltransferase Gene Encoding the Enzyme Catalyzing the First Step of
Mycothiol Biosynthesis (mshA)
Gerald L . Newton,1 Teresa Koledin,1 Batia
Gorovitz,2 Mamta Rawat,2 Robert C . Fahey,1*
and Yossef Av-Gay2
Department of Chemistry and Biochemistry, University of California, San
Diego, La Jolla, California 92093,1 Department of Medicine, Division
of Infectious Diseases, University of British Columbia, Vancouver, British
Columbia V5Z 3J5, Canada2
Received 18 October 2002/ Accepted 6 March 2003
Mycothiol is the major thiol present in most actinomycetes and is
produced from the pseudodisaccharide 1D-myo-inosityl
2-acetamido-2-deoxy- -D-glucopyranoside
(GlcNAc-Ins) . A transposon mutant of Mycobacterium smegmatis
shown to be GlcNAc-Ins and mycothiol deficient was sequenced to
identify a putative glycosyltransferase gene designated mshA .
The ortholog in Mycobacterium tuberculosis, Rv0486, was used
to complement the mutant phenotype .
Mycothiol (MSH) (Fig . 1) is the principal thiol found in
mycobacteria and most other actinomycetes . It appears to function in
many ways like glutathione, which is not produced by actinomycetes
(15) . This suggested that MSH metabolism might provide
suitable targets for new drugs directed against Mycobacterium
tuberculosis (13, 20,
21) . Support for this possibility came from studies
of Mycobacterium smegmatis chemical mutants blocked in MSH
biosynthesis . MSH mutants were shown to have enhanced sensitivity to
hydrogen peroxide and various toxins, including rifampin and other
antibiotics, but were found to be resistant to isoniazid (16,
17) . The enzymes involved in MSH biosynthesis
therefore appear to have potential as new drug targets . In this study
we identified a glycosyltransferase gene involved in an initial step
of MSH biosynthesis .
|
FIG . 1 . Structure and biosynthetic pathway for MSH . M . tuberculosis
genes encoding MshB (Rv1170; GlcNAc-Ins deacetylase) (14),
MshC (Rv2130c; ATP-dependent L-Cys:GlcN-Ins
ligase) (18), and MshD (Rv0819; acetyltransferase,
mycothiol synthase) (9) have been identified.
|
|
The pathway of MSH biosynthesis involves at least four enzymes, the
last three of which are known (Fig . 1) . To facilitate
identification of MSH biosynthesis genes, a Tn5 transposon
library enriched for MSH-deficient mutants was produced by selecting
for resistance to both kanamycin and isoniazid (9);
the latter resistance has been established as a phenotype which is
characteristic of MSH-deficient strains (16,
17) . One of three MSH-deficient mutants isolated
proved to be defective in the final step of MSH biosynthesis and was
used to identify mshD (9) . Here we characterized a
second mutant, tentatively designated mshA::Tn5 because
it was found to produce no measurable amount of the
pseudodisaccharide precursors of MSH, 1D-myo-inosityl
2-acetamido-2-deoxy- -D-glucopyranoside
(GlcNAc-Ins) and 1D-myo-inosityl
2-amino-2-deoxy- -D-glucopyranoside
(GlcN-Ins) (Table 1), which suggested that it was
defective in MshA . This is the same phenotype as that of M .
smegmatis chemical mutant strain 49 (14,
16) . In order to obtain a high-quality sequence at
the site of insertion, it was necessary to subclone SalI- or
PstI-digested genomic DNA from mshA::Tn5 into pUC18
as previously described (9) .
| TABLE 1 . Levels of MSH and its precursors in mshA mutants and
their complements
|
|
The SalI clone produced 205 bp of sequence, and the PstI clone
produced 822 bp of sequence, both at the same insertion site;
the PstI clone corresponded exactly to the complement of bases
507551 to 508372 of contig 3311 of the unfinished M . smegmatis
genome in The Institute for Genomic Research database (http://www.tigr.org) .
Since the M . smegmatis sequence has not been annotated yet,
the experimental sequence was used to search the M . tuberculosis
H37Rv GenBank genome database by using tblastx . This resulted
in identification of a 236-amino-acid sequence from open reading
frame Rv0486 having 84% identity with the translated experimental
sequence . Thus, the reading frame for the M . smegmatis sequence
was established, and a downstream stop codon defined the termination
site for the M . smegmatis gene . The start position for the gene
was thought to be defined by a GTG codon found upstream from
the end of the region with high identity to the M . tuberculosis
sequence and downstream from an in-frame stop codon . This resulted
in identification of the sequence for MshA, as shown in Fig .
2 . The M . smegmatis and M . tuberculosis MshA
sequences are 75% identical in a 446-residue overlap .
|
FIG . 2 . Alignment of the sequences of MshA from M . smegmatis
(MshA-Msmeg) and M . tuberculosis (MshA-Mtub) with the sequences
of SpsA from Anaebaena sp . strain PCC7120 (SpsA-Anab) and PimB
(Rv0557) from M . tuberculosis (PimB-Mtub) . The site of the G32D
mutation in M . smegmatis mutant 49 is indicated by an asterisk .
See the text for a discussion of specifically designated residues and
domains; the numbers are numbers in the M . tuberculosis MshA
sequence.
|
|
To verify that Rv0486 encodes the enzyme activity missing in the
transposon and chemical mutants, the gene was cloned into the pALACE
vector (an Escherichia coli-Mycobacterium shuttle
plasmid; Hygr; induced by acetamide and derived from pACE [6]
to introduce an N-terminal His6 tag) to produce pAL0486, which
was used to transform mshA::Tn5 and mutant 49 . M .
tuberculosis H37Rv genomic DNA was prepared as described
previously (2) . Open reading frame Rv0486 was
amplified by PCR by using this DNA and primers 486 PAL 3
(5'CATATGCACGGTCGGCAAGGAGG3') and 486 PAL 5
(5'AGGATCCATGGCAGGTGTGCGGCAC3') . These primers were designed to
contain NdeI and BamHI restriction sites, respectively .
PCR was performed as described previously (17), and the
appropriate PCR product was ligated into pALACE to obtain plasmid
pAL0486 . The pAL0486 plasmid was electroporated into the
MSH-deficient mutants, and selection was performed on plates
containing hygromycin for mutant 49 and hygromycin plus kanomycin for
mshA::Tn5 (16) .
In each case, two clones were selected from the hygromycin plates
for growth in liquid culture to produce cells for analysis of MSH and
its precursors . The results (Table 1) demonstrated that
full restoration of MSH production to wild-type levels occurred
with acetamide-induced cultures, and the levels of GlcNAc-Ins and
GlcN-Ins increased to normal or nearly normal levels in both mutants .
This confirmed that the loss of MSH biosynthesis capacity in mutant
mshA::Tn5 resulted solely from inactivation of the
mshA gene and demonstrated that mutant 49 was defective in the
mshA gene .
To ascertain the nature of the defect in the mshA gene of mutant
49, the mshA genes from the parent strain, M . smegmatis mc2155,
and mutant 49 were cloned and sequenced . The M . smegmatis sequence
obtained from The Institute for Genomic Research was used to
design primers upstream of the start codon (primer 49seq 5';
5'GCAACGAGAAGGCCGTCGAACT3') and downstream of the 3' region (primer
49seq 3'; 5'GTCCTCGATGATCTTCCTGACA3') of the mshA gene . The
primers were used to amplify the DNA from M . smegmatis mc2155
and from two different colonies of mutant 49, and each amplified
band was cloned into pCR2.1 (Invitrogen) . After we ensured by
restriction digestion that the M . smegmatis mshA gene had been
cloned, the DNA was sequenced by using primers 49seq 5' and 49seq 3',
as well as the universal primers T7 and M13R . To sequence the
internal region of the homolog and confirm the missense mutation, the
same procedure was followed with primers 49MED 5'
(5'GCGTGGCGGTGTTGTCGGTA3') and 49MED 3' (5'GACCAGTTGTTCGCGGCTCT3') .
Comparison of the sequences revealed a single base pair change in the
mutant which converted a GGC codon to GAC . This resulted in a change
in the amino acid at position 32 of the M . smegmatis sequence
from glycine in mc2155 to aspartic acid in mutant 49 (Fig.
2) .
The sensitivity of M . smegmatis parent strain mc2155,
transposon mutant mshA::Tn5, and chemical mutant 49 to
isoniazid was tested by using Estrips (Oxoid) and assessing
inhibition of growth after incubation for 2 to 3 days at 37°C . The
MICs of isoniazid determined were 1, >250, and >250 µg/ml,
respectively . The MICs of isoniazid for mc2155 and mutant
49 are similar to those obtained previously (2 and >50 µg/ml) by
plating on antibiotic-containing media (16) . When
the isoniazid sensitivities of the complemented mshA::Tn5
and strain 49 mutants were tested on plates containing 1% acetamide
but lacking glucose, the MICs were 2.7 and 28 µg/ml, respectively,
demonstrating that there was substantial reversion to the parental
phenotype . The mechanistic basis for the isoniazid resistance has not
been established, but there is evidence indicating that the isoniazid
sensitivity is specifically linked to MSH rather than a generally
high level of cellular thiol (9) .
The results described above establish that the mshA gene in
M . smegmatis is essential for the production of GlcNAc-Ins and
therefore for the synthesis of MSH . The M . tuberculosis mshA
gene, Rv0486, was previously identified by Campbell et al . (4)
(who listed it as unknown protein MTCY20G9.12) as a member of
glycosyltransferase family 4 in the CAZy database (http://afmb.cnrs-mrs.fr/CAZY/) .
This family includes a number of sucrose synthases, sucrose
phosphate synthases (Sps), mannosyl transferases, and GlcNAc
transferases . The most likely homologs for MshA seemed to be the
GlcNAc transferases PigA, which is involved in glycosyl
phosphatidylinositol anchor biosynthesis (8, 10),
and RfaK, which transfers GlcNAc from UDP to lipopolysaccharide (12),
but full sequence alignments revealed only 18 and 19% identities
between these sequences and the sequence of M . tuberculosis
MshA, respectively . Higher levels of identity were obtained
with sucrose and sucrose phosphate synthases and with the mannosyl
transferase PimB . Figure 2 includes sequences for SpsA from
Anabaena sp . strain PCC7120 (5) and PimB (Rv0557)
from M . tuberculosis (19) (GenBank
accession numbers
AJ302071 and
NP_215071, respectively) . SpsA has 29% overall sequence identity
with M . tuberculosis MshA, whereas PimB has 24% identity .
Cumino et al . (5) identified two highly conserved
motifs present in the glycosyltransferase domains of sucrose
phosphate synthases and sucrose synthases, designated box I and box
II, as shown in Fig . 2 . M . tuberculosis MshA
is identical to SpsA at 6 of 12 box I residues and at 17 of 25 box II
residues . The first Gly of box I is changed to Asp in M . smegmatis
mutant 49 . This results in complete loss of the ability to synthesize
GlcNAc-Ins, GlcN-Ins, and MSH in vivo, showing that this region is
critical to the activity of MshA . The box II domain contains the E-X7-E
signature (7) universally found in the retaining
glycosyl transferases of CAZy family 4, and the first residue of this
signature, E353 (M . tuberculosis numbering), has
been shown to be essential for activity of the mannosyl transferase
AceA from Acetobacter xylinum (1) . PimB is
less similar to SpsA than MshA is, but there are some additional
residues that were identified by Kremer et al . (11) as highly
conserved in mannosyl transferases that are conserved in MshA
and SpsA . These include Lys278, which has also been shown to
be essential for activity in AceA (1), as well as Gly241,
Asp243, and Arg273, for which no function has
been established yet (11) . The homology of MshA
with known CAZy family 4 glycosyltransferases clearly indicates that
MshA belongs to this group and is the glycosyltransferase required
for biosynthesis of the pseudodisaccharide GlcNAc-Ins (Fig.
1) . However, there has been no clear indication of
the nature of the substrate sugar donor or sugar acceptor .
The most obvious candidate for the biochemical reaction catalyzed
by MshA involves transfer of GlcNAc from UDP-GlcNAc to myo-inositol,
but we have not been able to detect production of GlcNAc-Ins
using these substrates and either crude extracts of M . smegmatis
or recombinant His6 MshA purified from mutant 49::pAL0486 on
an Ni2+ affinity column . Thus, the reaction either requires
some special conditions not yet identified or utilizes some
other combination of substrates . This is the subject of continuing
studies .
This work was supported by grants to R.C.F . from the National
Institute of Allergy and Infectious Diseases (grant AI49174) and the
Fogarty International Center (grant TW00976), and to Y.A . from the
British Columbia Lung Association and the TB Veterans Association .
Y.A . is a Canadian Institute of Health Research Foundation-BC Lung
Association Scholar . We thank Koen De Smet for kindly providing the
pALACE shuttle plasmid .
* Corresponding author . Mailing address: Depatment of Chemistry
and Biochemistry, University of California, San Diego, La Jolla, CA 92093-0506 .
Phone: (619) 534-2163 . Fax: (619) 534-4864 . E-mail: rcfahey@ucsd.edu .
- Abdian, P . L., A . C . Lellouch, C . Gautier, L . Ielpi, and R .
A . Geremia. 2000 . Identification of essential amino acids in the bacterial
-mannosyltransferase
AceA . J . Biol . Chem . 275:40568-40575 .
- Av-Gay, Y., S . Jamil, and S . J . Drews. 1999 . Expression
and characterization of the Mycobacterium tuberculosis serine/threonine
protein kinase pknB . Infect . Immun . 67:5676-5682 .
- Buchmeier, N., G . L . Newton, T . Koledin, and R . C . Fahey.
2003 . Association of mycothiol with protection of Mycobacterium
tuberculosis from toxic oxidants and antibiotics . Mol . Microbiol . 47:1723-1732.
- Campbell, J . A., G . J . Davies, V . Bulone, and B . Henrissat.
1997 . A classification of nucleotide-diphospho-sugar glycosyltransferases
based on amino acid sequence similarities . Biochem . J . 326:929-939.
- Cumino, A., L . Curatti, L . Giarrocco, and G . L . Salerno.
2002 . Sucrose metabolism: Anabaena sucrose-phosphate synthase and
sucrose-phosphate phosphatase define minimal functional domains shuffled
during evolution . FEBS Lett . 517:19-23.
- De Smet, K . A . L., K . E . Kempsell, A . Gallagher, K . Duncan,
and D . B . Young. 1999 . Alteration of a single amino acid residue reverses
fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis .
Microbiology 145:3177-3184 .
- Geremia, R . A., E . A . Petroni, L . Ielpi, and B . Henrissat.
1996 . Towards a classification of glycosyltransferases based on amino acid
sequence similarities: prokaryotic
-mannosyltransferases .
Biochem . J . 318:133-138.
- Kinoshita, T., and N . Inoue. 2000 . Dissecting and
manipulating the pathway for glycosylphosphatidylinositol-anchor biosynthesis .
Curr . Opin . Chem . Biol . 4:632-638.
- Koledin, T., G . L . Newton, and R . C . Fahey. 2002 .
Identification of the mycothiol synthase gene (mshD) encoding the
acetyltransferase producing mycothiol in actinomycetes . Arch . Microbiol .
178:331-337.
- Kostova, Z., D . M . Rancour, A . K . Menon, and P . Orlean.
2000 . Photoaffinity labelling with P3-(4-azidoanilido)uridine
5'-triphosphate identifies Gpi3p as the UDP-GlcNAc-binding subunit of the
enzyme that catalyses formation of GlcNAc-phosphatidylinositol, the first
glycolipid intermediate in glycosylphosphatidylinositol synthesis . Biochem . J.
350:815-822.
- Kremer, L., S . S . Gurcha, P . Bifani, P . G . Hitchen, A .
Baulard, H . R . Morris, A . Dell, P . J . Brennan, and G . S . Besra. 2002 .
Characterization of a putative
-mannosyltransferase
involved in phosphatidylinositol trimannoside biosynthesis in Mycobacterium
tuberculosis . Biochem . J . 363:437-447.
- MacLachlan, P . R., S . K . Kadam, and K . E . Sanderson.
1991 . Cloning, characterization, and DNA sequence of the rfaLK region
for lipopolysaccharide synthesis in Salmonella typhimurium LT2 . J .
Bacteriol . 173:7151-7163.
- Newton, G . L., K . Arnold, M . S . Price, C . Sherrill, S . B .
delCardayré, Y . Aharonowitz, G . Cohen, J . Davies, R . C . Fahey, and C . Davis.
1996 . Distribution of thiols in microorganisms: mycothiol is a major thiol in
most actinomycetes . J . Bacteriol . 178:1990-1995.
- Newton, G . L., Y . Av-Gay, and R . C . Fahey. 2000 . N-Acetyl-1-D-myo-inosityl-2-amino-2-deoxy-
-D-glucopyranoside
deacetylase (MshB) is a key enzyme in mycothiol biosynthesis . J . Bacteriol .
182:6958-6963 .
- Newton, G . L., and R . C . Fahey. 2002 . Mycothiol
biochemistry . Arch . Microbiol . 178:388-394.
- Newton, G . L., M . D . Unson, S . J . Anderberg, J . A . Aguilera,
N . N . Oh, S . B . delCardayré, J . Davies, Y . Av-Gay, and R . C . Fahey. 1999 .
Characterization of a Mycobacterium smegmatis mutant defective in 1-D-myo-inosityl-2-amino-2-deoxy-
-D-glucopyranoside
and mycothiol biosynthesis . Biochem . Biophys . Res . Commun . 255:239-244.
- Rawat, M., G . L . Newton, M . Ko, G . J . Martinez, R . C . Fahey,
and Y . Av-Gay. 2002 . Mycothiol-deficient mutants in Mycobacterium
smegmatis are hypersensitive to alkylating agents, free radicals, and
antibiotics . Antimicrob . Agents Chemother . 46:3348-3355 .
- Sareen, D., M . Steffek, G . L . Newton, and R . C . Fahey.
2002 . ATP-dependent L-cysteine:1D-myo-inosityl
2-amino-2-deoxy-
-D-glucopyranoside
ligase:mycothiol biosynthesis enzyme MshC is related to class I cysteinyl-tRNA
synthetases . Biochemistry 41:6885-6890.
- Schaeffer, M . L., K . H . Khoo, G . S . Besra, D . Chatterjee, P .
J . Brennan, J . T . Belisle, and J . M . Inamine. 1999 . The pimB gene
of Mycobacterium tuberculosis encodes a mannosyltransferase involved in
lipoarabinomannan biosynthesis . J . Biol . Chem . 274:31625-31631 .
- Spies, H . S., and D . J . Steenkamp. 1994 . Thiols of
intracellular pathogens . Identification of ovothiol A in Leishmania
donovani and structural analysis of a novel thiol from Mycobacterium
bovis . Eur . J . Biochem . 224:203-213.
- Young, D . B., and K . Duncan. 1995 . Prospects for new
interventions in the treatment and prevention of mycobacterial disease . Annu .
Rev . Microbiol . 49:641-673.
Free Online Full-text Article
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
|